These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 33191260)

  • 21. Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial.
    McKee JB; Elston J; Evangelou N; Gerry S; Fugger L; Kennard C; Kong Y; Palace J; Craner M
    BMJ Open; 2015 Nov; 5(11):e009200. PubMed ID: 26553836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol.
    Bhatt SP; Connett JE; Voelker H; Lindberg SM; Westfall E; Wells JM; Lazarus SC; Criner GJ; Dransfield MT
    BMJ Open; 2016 Jun; 6(6):e012292. PubMed ID: 27267111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double blind, randomised, placebo-controlled trial to evaluate the efficacy of metformin to treat preterm pre-eclampsia (PI2 Trial): study protocol.
    Cluver C; Walker SP; Mol BW; Hall D; Hiscock R; Brownfoot FC; Kaitu'u-Lino TJ; Tong S
    BMJ Open; 2019 Apr; 9(4):e025809. PubMed ID: 31023758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neonatal azithromycin administration to prevent infant mortality: study protocol for a randomised controlled trial.
    Sie A; Bountogo M; Nebie E; Ouattara M; Coulibaly B; Bagagnan C; Zabre P; Lebas E; Brogdon J; Godwin WW; Lin Y; Porco T; Doan T; Lietman TM; Oldenburg CE;
    BMJ Open; 2019 Sep; 9(9):e031162. PubMed ID: 31488494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trial protocol of the ASTER trial: a double-blind, randomized, placebo-controlled phase III trial evaluating the use of acetylsalicylic acid (ASA) for enhanced early detection of colorectal neoplasms.
    Tikk K; Czock D; Haefeli WE; Kopp-Schneider A; Brenner H
    BMC Cancer; 2018 Sep; 18(1):914. PubMed ID: 30249195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of diet, exercise and lifestyle (MODEL) study: a randomised controlled trial protocol.
    Radavelli-Bagatini S; Bondonno CP; Sim M; Blekkenhorst LC; Anokye R; Connolly E; Bondonno NP; Schousboe JT; Woodman RJ; Zhu K; Szulc P; Jackson B; Dimmock J; Schlaich MP; Cox KL; Kiel DP; Lim WH; Stanley M; Devine A; Thompson PL; Gianoudis J; De Ross B; Daly RM; Lewis JR; Hodgson JM
    BMJ Open; 2020 Nov; 10(11):e036366. PubMed ID: 33177129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled trial of aspirin and exertional heat stress activation of platelets in firefighters during exertion in thermal protective clothing.
    Hostler D; Suyama J; Guyette FX; Moore CG; Pryor RR; Khorana P; McEntire SJ; Comer D; Reis SE
    Prehosp Emerg Care; 2014; 18(3):359-67. PubMed ID: 24548114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Miller AE; Wolinsky JS; Kappos L; Comi G; Freedman MS; Olsson TP; Bauer D; Benamor M; Truffinet P; O'Connor PW;
    Lancet Neurol; 2014 Oct; 13(10):977-86. PubMed ID: 25192851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of Senior Dance on risk factors for falls in older adults (DanSE): a study protocol for a randomised controlled trial.
    Franco MR; Sherrington C; Tiedemann A; Pereira LS; Perracini MR; Faria CR; Pinto RZ; Pastre CM
    BMJ Open; 2016 Dec; 6(12):e013995. PubMed ID: 28039296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial.
    Urbi B; Broadley S; Bedlack R; Russo E; Sabet A
    BMJ Open; 2019 Nov; 9(11):e029449. PubMed ID: 31719072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a training programme of functional electrical stimulation (FES) powered cycling, recreational cycling and goal-directed exercise training on children with cerebral palsy: a randomised controlled trial protocol.
    Armstrong EL; Boyd RN; Kentish MJ; Carty CP; Horan SA
    BMJ Open; 2019 Jun; 9(6):e024881. PubMed ID: 31213443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of erythropoietin on cycling performance of well trained cyclists: a double-blind, randomised, placebo-controlled trial.
    Heuberger JAAC; Rotmans JI; Gal P; Stuurman FE; van 't Westende J; Post TE; Daniels JMA; Moerland M; van Veldhoven PLJ; de Kam ML; Ram H; de Hon O; Posthuma JJ; Burggraaf J; Cohen AF
    Lancet Haematol; 2017 Aug; 4(8):e374-e386. PubMed ID: 28669689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early PARacetamol (EPAR) trial: a study protocol for a randomised controlled trial of early paracetamol to promote closure of the ductus arteriosus in preterm infants.
    Schindler T; Smyth J; Bolisetty S; Michalowski J; Lui K
    BMJ Open; 2019 Oct; 9(10):e031428. PubMed ID: 31666270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Cree BAC; Cutter G; Wolinsky JS; Freedman MS; Comi G; Giovannoni G; Hartung HP; Arnold D; Kuhle J; Block V; Munschauer FE; Sedel F; Lublin FD;
    Lancet Neurol; 2020 Dec; 19(12):988-997. PubMed ID: 33222767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial.
    Wolinsky JS; Arnold DL; Brochet B; Hartung HP; Montalban X; Naismith RT; Manfrini M; Overell J; Koendgen H; Sauter A; Bennett I; Hubeaux S; Kappos L; Hauser SL
    Lancet Neurol; 2020 Dec; 19(12):998-1009. PubMed ID: 33129442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT).
    Lyttle MD; Bielicki JA; Barratt S; Dunn D; Finn A; Harper L; Jackson P; Powell CVE; Roland D; Stohr W; Sturgeon K; Wan M; Little P; Faust SN; Robotham J; Hay AD; Gibb DM; Sharland M;
    BMJ Open; 2019 May; 9(5):e029875. PubMed ID: 31123008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomised controlled trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the step it up study protocol.
    Coote S; Gallagher S; Msetfi R; Larkin A; Newell J; Motl RW; Hayes S
    BMC Neurol; 2014 Dec; 14():241. PubMed ID: 25528262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SUcceSS, SUrgery for Spinal Stenosis: protocol of a randomised, placebo-controlled trial.
    Anderson DB; Ferreira ML; Harris IA; Davis GA; Stanford R; Beard D; Li Q; Jan S; Mobbs RJ; Maher CG; Yong R; Zammit T; Latimer J; Buchbinder R
    BMJ Open; 2019 Feb; 9(2):e024944. PubMed ID: 30765407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.